Castellani Stefano, Favia Maria, Guerra Lorenzo, Carbone Annalucia, Abbattiscianni Anna Claudia, Di Gioia Sante, Casavola Valeria, Conese Massimo
Laboratory of Experimental and Regenerative Medicine, Department of Medical and Surgical Sciences, University of Foggia, Foggia, Italy.
Department of Biosciences, Biotechnologies and Biopharmaceutics, University of Bari, Bari, Italy.
Histol Histopathol. 2017 May;32(5):445-459. doi: 10.14670/HH-11-842. Epub 2016 Nov 11.
Cystic fibrosis (CF), one of the most common genetic disorders affecting primarily Caucasians, is due to mutations in the CF Transmembrane Conductance Regulator (CFTR) gene, encoding for a chloride channel also acting as regulator of other transmembrane proteins. In healthy subjects, CFTR is maintained in its correct apical plasma membrane location via the formation of a multiprotein complex in which scaffold proteins (such as NHERF1) and signaling molecules (such as cAMP and protein kinases) guarantee its correct functioning. In CF, a disorganized and dysfunctional airway epithelium brings an altered flux of ions and water into the lumen of bronchioles, consequent bacterial infections and an enormous influx of inflammatory cells (mainly polymorphonuclear neutrophils) into the airway lumen. Recent evidence in healthy airway cells supports the notion that CFTR protein/function is strictly correlated with the actin cytoskeleton and tight junctions status. In CF cells, the most frequent CFTR gene mutation, F508del, has been shown to be associated with a disorganized actin cytoskeleton and altered tight junction permeability. Thus, the correct localization of CFTR on the apical plasma membrane domain through the formation of the scaffolding and signaling complex is likely fundamental to determine a physiological airway epithelium. The correction of CFTR mutations by either gene or drug therapies, as well as by stem cell-based interventions, can determine the resumption of a physiological organization of actin stress fibers and TJ structure and barrier function, further indicating the close interrelationship among these processes.
囊性纤维化(CF)是主要影响白种人的最常见遗传疾病之一,它是由囊性纤维化跨膜传导调节因子(CFTR)基因突变引起的,该基因编码一种氯离子通道,同时也作为其他跨膜蛋白的调节因子。在健康个体中,CFTR通过形成多蛋白复合物维持在其正确的顶端质膜位置,其中支架蛋白(如NHERF1)和信号分子(如cAMP和蛋白激酶)保证其正常功能。在CF患者中,气道上皮组织紊乱且功能失调,导致离子和水向细支气管管腔的流量改变,进而引发细菌感染,大量炎症细胞(主要是多形核中性粒细胞)涌入气道管腔。最近在健康气道细胞中的证据支持了CFTR蛋白/功能与肌动蛋白细胞骨架和紧密连接状态密切相关的观点。在CF细胞中,最常见的CFTR基因突变F508del已被证明与肌动蛋白细胞骨架紊乱和紧密连接通透性改变有关。因此,通过形成支架和信号复合物使CFTR在顶端质膜结构域正确定位,可能是决定生理性气道上皮的关键。通过基因治疗、药物治疗以及基于干细胞的干预来纠正CFTR突变,可以使肌动蛋白应力纤维和紧密连接结构及屏障功能恢复生理组织状态,进一步表明这些过程之间存在密切的相互关系。